According to the statistic, biotech company Legend Biotech had an IPO valued at 487.3 million U.S. dollars. This statistic shows the leading 20 U.S. biotech companies by value of their initial public offerings (IPOs) as reported for 2020.
Value of leading 20 U.S. biotech initial public offerings (IPOs) in 2020
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
EY. (April 1, 2021). Value of leading 20 U.S. biotech initial public offerings (IPOs) in 2020 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 24, 2022, from https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY. "Value of leading 20 U.S. biotech initial public offerings (IPOs) in 2020 (in million U.S. dollars)." Chart. April 1, 2021. Statista. Accessed May 24, 2022. https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY. (2021). Value of leading 20 U.S. biotech initial public offerings (IPOs) in 2020 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 24, 2022. https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY. "Value of Leading 20 U.S. Biotech Initial Public Offerings (Ipos) in 2020 (in Million U.S. Dollars)." Statista, Statista Inc., 1 Apr 2021, https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/
EY, Value of leading 20 U.S. biotech initial public offerings (IPOs) in 2020 (in million U.S. dollars) Statista, https://www.statista.com/statistics/859005/value-of-us-and-eu-biotech-ipos/ (last visited May 24, 2022)
